BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16041764)

  • 1. Lipoxygenase inhibitors from natural plant sources. Part 2: medicinal plants with inhibitory activity on arachidonate 12-lipoxygenase, 15-lipoxygenase and leukotriene receptor antagonists.
    Schneider I; Bucar F
    Phytother Res; 2005 Apr; 19(4):263-72. PubMed ID: 16041764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoxygenase inhibitors from natural plant sources. Part 1: Medicinal plants with inhibitory activity on arachidonate 5-lipoxygenase and 5-lipoxygenase[sol ]cyclooxygenase.
    Schneider I; Bucar F
    Phytother Res; 2005 Feb; 19(2):81-102. PubMed ID: 15852496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotrienes in respiratory disease.
    McMillan RM
    Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
    Drazen JM
    Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing 12(S)-lipoxygenase inhibitory activity using colorectal cancer cells overexpressing the enzyme.
    Bednar W; Holzmann K; Marian B
    Food Chem Toxicol; 2007 Mar; 45(3):508-14. PubMed ID: 17027136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photoactivation of an inhibitor of the 12/15-lipoxygenase pathway.
    Herre S; Schadendorf T; Ivanov I; Herrberger C; Steinle W; Rück-Braun K; Preissner R; Kuhn H
    Chembiochem; 2006 Jul; 7(7):1089-95. PubMed ID: 16755628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 5-lipoxygenase product synthesis by natural compounds of plant origin.
    Werz O
    Planta Med; 2007 Oct; 73(13):1331-57. PubMed ID: 17939102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoxygenase inhibitors for the treatment of pancreatic cancer.
    Kennedy TJ; Chan CY; Ding XZ; Adrian TE
    Expert Rev Anticancer Ther; 2003 Aug; 3(4):525-36. PubMed ID: 12934664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of 5-lipoxygenase inhibitors and leukotriene receptor antagonists in the treatment of chronic asthma.
    Sorkness CA
    Pharmacotherapy; 1997; 17(1 Pt 2):50S-54S. PubMed ID: 9017788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New frontiers in asthma therapy: leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Introduction.
    Hendeles L
    Pharmacotherapy; 1997; 17(1 Pt 2):1S-2S. PubMed ID: 9017782
    [No Abstract]   [Full Text] [Related]  

  • 11. 1'-Hydroxyeugenol- and coniferyl alcohol derivatives as effective inhibitors of 5-lipoxygenase and Cu(2+)-mediated low density lipoprotein oxidation. Evidence for a dual mechanism.
    Deigner HP; Wolf G; Ohlenmacher U; Reichling J
    Arzneimittelforschung; 1994 Aug; 44(8):956-61. PubMed ID: 7945541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Substances affecting the synthesis and activity of leukotrienes].
    Opletalová V; Hartl J; Bĕhounková M
    Ceska Slov Farm; 1997 Apr; 46(2):51-7. PubMed ID: 9244564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of leukotrienes in pathophysiology of bronchial asthma--therapy perspectives].
    Wojnowski P; Patkowski J
    Postepy Hig Med Dosw; 1997; 51(5):499-514. PubMed ID: 9489451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Lipoxygenase: a target for antiinflammatory drugs revisited.
    Steinhilber D
    Curr Med Chem; 1999 Jan; 6(1):71-85. PubMed ID: 9873115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotriene modifiers in the treatment of cardiovascular diseases.
    Riccioni G; Capra V; D'Orazio N; Bucciarelli T; Bazzano LA
    J Leukoc Biol; 2008 Dec; 84(6):1374-8. PubMed ID: 18794213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of the 5-lipoxygenase pathway in atherosclerosis.
    Bäck M
    Curr Pharm Des; 2009; 15(27):3116-32. PubMed ID: 19754386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene-receptor antagonists and 5-lipoxygenase inhibitors in asthma.
    Larsen JS; Acosta EP
    Ann Pharmacother; 1993; 27(7-8):898-903. PubMed ID: 8364276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopharmacological role of the leukotriene receptor antagonists and inhibitors of leukotrienes generating enzymes in multiple sclerosis.
    Mirshafiey A; Jadidi-Niaragh F
    Immunopharmacol Immunotoxicol; 2010 Jun; 32(2):219-27. PubMed ID: 20298145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arachidonate 12-lipoxygenases with reference to their selective inhibitors.
    Yamamoto S; Katsukawa M; Nakano A; Hiraki E; Nishimura K; Jisaka M; Yokota K; Ueda N
    Biochem Biophys Res Commun; 2005 Dec; 338(1):122-7. PubMed ID: 16171776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileukotriene agents.
    Tan RA; Spector SL
    Curr Opin Pulm Med; 1997 May; 3(3):215-20. PubMed ID: 9232368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.